Corporate Banner
Satellite Banner
RNAi
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Over 20 industry experts on Inhalaltion Drug Delivery to gather in Berlin on 11 - 12 September 2013

Published: Thursday, August 22, 2013
Last Updated: Thursday, August 22, 2013
Bookmark and Share
CPhI Conferences introduces its inaugural conference on Inhalation Drug Delivery, to cover topics from particle engineering to device manufacture.

The potential of a pulmonary route as a non-invasive administration for systemic delivery of therapeutic agents has been receiving an undeniable attention with the recent advances of the inhalation drug delivery showing significant promise.  The crucial formulation considerations for orally inhaled products together with those of a delivery device play a major role in the efficiency of pulmonary delivery, and great strides have been made in the development of new formulation techniques and devices in recent years.

With this in mind, CPhI Conferences, is proud to present its inaugural conference on Inhalation Drug Delivery which has been designed to examine all the important aspects of pulmonary drug delivery, from particle engineering to device manufacturing.

Over the course of two intensive days there will be practical and informative sessions examining technical, physiological, and efficacy aspects of the novel pulmonary route of drug targeting. It will share important insights into the mechanisms of pulmonary drug administration along with compatibility of the excipients employed, devices used, and techniques of particulate dosage production.

This is an essential opportunity to understand the challenges facing the development of pulmonary drug delivery system and discover the opportunities for the pharmaceutical scientists to minimize the clinical and technical gaps.

In addition to the main conference, CPhI is also running a Pre-Conference Workshop on Nasal Drug Delivery providing hands-on, practical guidance on how to capitalise on the full potential of delivering drugs via the nasal route.

The conference will include industry professionals from a range of organisations including MHRA, Catalent, Glenmark, Hovione, Medicon Valley Inhalation Consortium, KAER Biotherapeutics, Nonomol Technologies and many more. With expert speakers from the world of pulmonary drug delivery across Europe and globally, this conference offers the opportunity to network and debate with leaders in this field.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,300+ scientific posters on ePosters
  • More than 4,800+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Liquid Biopsies: Miracle Diagnostic or Next New Fad?
Thanks to the development of highly specific gene-amplification and sequencing technologies liquid biopsies access more biomarkers relevant to more cancers than ever before.
Discovered Through ‘Big Data’ Analysis
Researchers at the SBP have identified over 100 new genetic regions that affect the immune response to cancer.
New Therapeutic Targets For Small Cell Lung Cancer Identified
Researchers at UTSW Medical Center have identified a protein termed ASCL1 that is essential to the development of small cell lung cancer and that, when deleted in the lungs of mice, prevents the cancer from forming.
Liquid Biopsies Treating Ovarian Cancer
Researchers have discovered a promising monitor and treat recurrence of ovarian cancer. Detecting cancer long before tumours reappear.
Virus Inspired Cell Cargo Ships
Virus-inspired container design may lead to cell cargo ships following construction of ten large, two-component, icosahedral protein complexes.
Uncovering a New Principle in Chemotherapy Resistance in Breast Cancer
The NIH study has revealed an entirely unexpected process for acquiring drug resistance that bypasses the need to re-establish DNA damage repair in breast cancers that have mutant BRCA1 or BRCA2 genes.
Understanding Treatment Resistant Melanoma
Researchers have determined how advanced melanoma becomes resistant; a development toward developing treatments.
Liquid Biopsies: DNA Size Matters
Study finds circulating tumour DNA can be distinguished from healthy DNA through fragment size identification.
Unravelling the Roots of Insect’s Waterproof Coating
Researchers have identified the genes that control cuticular lipid production in Drosophila, by performing an RNAi screen and using Direct Analysis in Real Time and GC-MS.
Identifying Cancer Drug Targets Using 3D-Modelling
Researchers are now able to model genetic mutations manipulation of proteins that can potentially drive cancer.
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!